0001209191-15-039175.txt : 20150506
0001209191-15-039175.hdr.sgml : 20150506
20150506083831
ACCESSION NUMBER: 0001209191-15-039175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150504
FILED AS OF DATE: 20150506
DATE AS OF CHANGE: 20150506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Eric
CENTRAL INDEX KEY: 0001601797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 15835201
MAIL ADDRESS:
STREET 1: GOODWIN PROCTER LLP
STREET 2: 53 STATE ST
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-04
0
0001293971
bluebird bio, Inc.
BLUE
0001601797
Sullivan Eric
C/O BLUEBIRD BIO, INC.
150 SECOND STREET
CAMBRIDGE
MA
02141
0
1
0
0
Principal Accounting Officer
Common Stock
2015-05-04
4
M
0
250
20.70
A
566
D
Common Stock
2015-05-04
4
M
0
166
24.47
A
732
D
Common Stock
2015-05-04
4
S
0
189
131.2736
D
543
D
Common Stock
2015-05-04
4
S
0
148
131.9554
D
395
D
Common Stock
2015-05-04
4
S
0
79
132.9613
D
316
D
Stock Options (right to buy)
20.70
2015-05-04
4
M
0
250
0.00
D
2023-12-02
Common Stock
250
7500
D
Stock Option (right to buy)
24.47
2015-05-04
4
M
0
166
0.00
D
2024-03-03
Common Stock
166
5336
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015.
The range in prices for the transaction reported on this line was $130.50 to $131.50. The average weighted price was $131.2736. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $131.51 to $132.50. The average weighted price was $131.9554. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $132.75 to $133.27. The average weighted price was $132.9613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
/s/ Jason F. Cole, Attorney-in-Fact
2015-05-06